CompletedInterventionalPhase 4Updated Aug 10, 2010
Intraoperative Floppy Iris Syndrome
ClinicalTrials.gov ID
NCT00711347
Lead Sponsor
Alcon ResearchINDUSTRY
Overall Status
Completed
Study Type
Interventional
Phase
Phase 4
Enrollment
28Actual
Last Update Posted
Aug 10, 2010Estimated
Start Date
Jun 2007
Primary Completion Date
Apr 2008Actual
Completion Date
Apr 2008Actual
Brief Summary
An assessment of the surgical performance of DisCoVisc compared to Healon5 during cataract surgery with intraocular lens implantation where miotic/small pupils or intraoperative Floppy Iris Syndrome exists.
Cataract
Floppy Iris Syndrome
DisCoVisc
Healon5
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
diagnosed with floppy iris syndrome
operable bilateral cataracts
Exclusion Criteria:
Intraocular Pressure (IOP) > 21mmHg
ocular inflammatory disease
systemic or ocular diseases affecting Endothelial Cell Count